Peter Y. Tam President

Mr. Tam has been President since December 2009. Prior to that time, Mr. Tam held various senior management positions at VIVUS, including senior vice president of product and corporate development and vice president of strategic planning and corporate development. Mr. Tam joined VIVUS in 1993 as manager of clinical research, and in 1999 he assumed the responsibilities of director of clinical and corporate development. Prior to VIVUS, Mr. Tam held various research and clinical development positions at Genentech from 1991 through 1993 and XOMA Corporation from 1987 to 1991. Mr. Tam received a B.S. in Chemistry from University of California Berkeley in 1986 and his M.B.A. at Santa Clara University in 2000.

Wesley W. Day, Ph.D. Vice President, Clinical Development

Dr. Day has been the vice president of clinical development since November 2005. Prior to joining VIVUS, Dr. Day held a variety of positions with Pfizer, Inc. from 1993 until his departure in October 2005. Most recently, Dr. Day was the senior director, safety risk management from September 2003 until his departure. Prior to this position, Dr. Day served as the senior associate director, worldwide regulatory affairs from August 2001 to 2003, associate director II, worldwide regulatory affairs from 2000 to 2001, associate director I, clinical development from 1999 to 2000, senior clinical research investigator from 1997 to 1998, senior research scientist from 1995 to 1997 and research scientist from 1993 to 1994. Dr. Day holds a Ph.D. in pharmacology and toxicology from the University of Maryland at Baltimore, a B.S. with Highest Honors from the University of Texas at Pan American. Dr. Day is an adjunct associate professor for the School of Pharmacy at the University of Maryland at Baltimore where he has held an adjunct appointment since 1995. He has also been an adjunct assistant professor for Temple University.

Guy P. Marsh Vice President of U.S. Operations & General Manager

Mr. Marsh has been vice president of U.S. Operations and general manager for VIVUS since July 2000. In 2001, Mr. Marsh assumed responsibilities for U.S. Sales and Marketing of MUSE. Mr. Marsh joined VIVUS in May 1998 in the position of senior director, U.S. Operations, and assumed the responsibilities of general manager, Operations in April 1999. Prior to joining VIVUS, Mr. Marsh served as vice president technical operations for Copley Pharmaceutical, Inc. from April 1994 to April 1998. Also during this period, Mr. Marsh served as a liaison between Copley Pharmaceutical and Copley’s majority stockholder, Hoechst-Celanese Corporation. From November 1987 to April 1994, Mr. Marsh served in various manufacturing, sales and business management roles for Hoechst-Roussel Pharmaceuticals, Inc. Mr. Marsh received a B.S. in Engineering from New Jersey Institute of Technology, holds a New Jersey State Professional Engineering License, and received an MBA from Seton Hall University.

Timothy E. Morris Vice President, Finance & Chief Financial Officer This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Mr. Morris has been vice president, finance and chief financial officer since November 2004. Prior to joining VIVUS, Mr. Morris served as member of the office of the president, chief financial officer and senior vice president of finance & administration at Questcor Pharmaceuticals Inc. from September 2001 to November 2004. Prior to this position, Mr. Morris served as vice president of finance & administration and chief financial officer at RiboGene, Inc., the predecessor company to Questcor, from May 1995 to October 1999. Prior to RiboGene, Mr. Morris was at Glycomed Incorporated from May 1992 to May 1995 most recently as chief accounting officer, acting chief financial officer and senior director, finance. Mr. Morris earned a BS degree, cum laude, in Business with an emphasis in Accounting from California State University, Chico, and in 1996 Mr. Morris became a certified public accountant.

Lee B. Perry Vice President and Chief Accounting Officer

Mr. Perry has served as the company's vice president and chief accounting officer since February 2007. His responsibilities include oversight of the company's accounting operations and systems, external reporting, financial planning and analysis, cost accounting, internal controls, taxation and risk management. Mr. Perry has over 30 years experience in corporate finance and operations and public accounting. For the past twenty years he has held senior financial positions in life sciences and manufacturing industries. Prior to VIVUS, his life science experience included serving as senior director of finance at Questcor Pharmaceuticals, Inc. and as director of finance at DNA Sciences, Inc. Mr. Perry also served as chief financial officer of BHP Coated Steel, Corp. Mr. Perry earned his BA degree in economics from San Diego State University and is a certified public accountant.

Virgil A. Place, M.D. Founder & Chief Scientific Officer

Dr. Place is the founder of VIVUS and has been its chief scientific officer since the company was formed in April 1991, and was the chairman of the board from that time until April 2007. Before joining VIVUS, Dr. Place was principal scientist and held a variety of executive positions including vice president of medical and regulatory affairs at ALZA Corporation from 1969 to 1991. In addition, Dr. Place served nine years on the ALZA Corporation board of directors. He received a B.A. in Chemistry from Indiana University and an M.D. from Johns Hopkins University. He is board certified in internal medicine, with specialty training at the Mayo Clinic.